Citazione APA

Sekiguchi, N., Hamano, A., Kitagawa, T., Ito, K., Hirano, K., & Yamada, K. (2019). What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness. Blood Res.

Stile di citazione Chicago

Sekiguchi, Naohiro, Airi Hamano, Tomoko Kitagawa, Kenichi Ito, Kazuhiko Hirano, e Kazuaki Yamada. "What Is the Most Appropriate Regimen for Untreated Waldenström Macroglobulinemia? - An Updated Analysis of Rituximab and Half-dose CHOP Therapy and Cost Effectiveness." Blood Res 2019.

Citazione MLA

Sekiguchi, Naohiro, et al. "What Is the Most Appropriate Regimen for Untreated Waldenström Macroglobulinemia? - An Updated Analysis of Rituximab and Half-dose CHOP Therapy and Cost Effectiveness." Blood Res 2019.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.